Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: CLL/SLL

NY-Presbyterian/Columbia Univ. Medical Center Investigator on Shorter Treatment Time for Some with CLL

Nicole Lamanna, investigator with New York-Presbyterian/Columbia University Medical Center was highlighted recently in Cure Today by Kristie L. Kahl.  Ms. […]

Cancer Drug
2 years ago
Share

Jacqueline Barrientos Discusses Emerging Agents Leading to Extended Survival & Reduced Toxicity in CLL

Follow the link to Targeted Oncology for a breakdown of advances in treating chronic lymphocytic leukemia (CLL) as new agents, […]

Chronic Lymphocytic Leukemia
2 years ago
Share

Trial Watch: AbbVie’s IMBRUVICA® Data in CLL Show Up to 7-Years of PFS in 80% Untreated Patients

AbbVie secured ownership of IMBRUVICA® (ibrutinib) in 2015 when it purchased Pharmacyclics. AbbVie reported $2.5 billion in sales with a […]

AbbVie’s IMBRUVICA
2 years ago
Share

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.